(Q42575209)

2 November 2017

Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia (English)

1 reference

2 November 2017

1 reference

Raymond C Barfield

7

0 references

Alice L Yu

object named as

Alice L Yu

9

0 references

author name string

Linda S Sorkin

1

1 reference

2 November 2017

Mario Otto

2

1 reference

2 November 2017

William M Baldwin

3

1 reference

2 November 2017

Emily Vail

4

1 reference

2 November 2017

Stephen D Gillies

5

1 reference

2 November 2017

Rupert Handgretinger

6

1 reference

2 November 2017

Hui Ming Yu

8

1 reference

2 November 2017

language of work or name

English

0 references

publication date

19 February 2010

1 reference

2 November 2017

1 reference

2 November 2017

149

1 reference

2 November 2017

1

1 reference

2 November 2017

135-142

1 reference

Targeting complement in therapy

2 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Electrophysiological characteristics of primary afferent fibers after systemic administration of anti-GD2 ganglioside antibody

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Generation of diacylglycerol and ceramide during homologous complement activation.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Membrane signaling by complement C5b-9, the membrane attack complex

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Quantitative assessment of tactile allodynia in the rat paw

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Efficient analysis of experimental observations.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Inflammatory mediators in demyelinating disorders of the CNS and PNS

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Release of histamine from rat mast cells by the complement peptides C3a and C5a.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Complement activation in the peripheral nervous system following the spinal nerve ligation model of neuropathic pain

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Blockade of the complement C5a receptor reduces incisional allodynia, edema, and cytokine expression

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Antibody directed against GD(2) produces mechanical allodynia, but not thermal hyperalgesia when administered systemically or intrathecally despite its dependence on capsaicin sensitive afferents

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Gabapentin reverses the allodynia produced by the administration of anti-GD2 ganglioside, an immunotherapeutic drug

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Intravenous lidocaine: effects on controlling pain after anti-GD2 antibody therapy in children with neuroblastoma--a report of a series.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755890

Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis

16 August 2018

1 reference

12 December 2020

Sublytic C5b-9-stimulated Schwann cell survival through PI 3-kinase-mediated phosphorylation of BAD

1 reference

12 December 2020

A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats

1 reference

12 December 2020

The role of the polymorphonuclear leukocyte in hyperalgesia

1 reference

12 December 2020

Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis

1 reference

12 December 2020

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma

1 reference

12 December 2020

High-level expression of chimeric antibodies using adapted cDNA variable region cassettes

1 reference

12 December 2020

A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a

1 reference

12 December 2020

Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord

1 reference

12 December 2020

Complement and clusterin in the spinal cord dorsal horn and gracile nucleus following sciatic nerve injury in the adult rat

1 reference

12 December 2020

Time-resolved fluorometric assay for natural killer activity using target cells labelled with a fluorescence enhancing ligand

1 reference

12 December 2020

An animal model of pain produced by systemic administration of an immunotherapeutic anti-ganglioside antibody

1 reference

12 December 2020

Activation of the spinal cord complement cascade might contribute to mechanical allodynia induced by three animal models of spinal sensitization

1 reference

12 December 2020

JNK1 activation mediates C5b-9-induced P0 mRNA instability and P0 gene expression in Schwann cells

1 reference

12 December 2020

Complement activation contributes to leukocyte recruitment and neuropathic pain following peripheral nerve injury in rats

1 reference

12 December 2020

10.1016/J.PAIN.2010.01.024

Identifiers

DOI

1 reference

2 November 2017

1 reference

2 November 2017

PubMed publication ID

20171010

1 reference